Story
Lemonade Stock Falls After Morgan Stanley Downgrade
Summary
Shares of insurance technology company Lemonade slid over 9% after Morgan Stanley lowered its rating on the stock, citing its rapid price appreciation over the past month. The move was reinforced by a maintained "Underperform" rating from Keefe, Bruyette & Woods.
Shares of Lemonade (NYSE: LMND) fell sharply during Tuesday's trading session, declining by as much as 9.1% in the morning. The primary catalyst for the sell-off was a downgrade from Morgan Stanley, which changed its rating on the stock from "Overweight" to "Equalweight."
Morgan Stanley's decision was based on valuation, with the firm pointing to the stock's significant run-up of approximately 50% over the prior month. With the share price having surpassed the firm's $75 price target, analysts viewed the near-term risk-reward as less compelling. The firm did note, however, that it still believes in Lemonade's long-term, tech-enabled growth potential.
Adding to the pressure, investment bank Keefe, Bruyette & Woods (KBW) reiterated its "Underperform" rating on Lemonade. KBW raised its price target modestly to $48 from $44, but this still represents a significant gap below the stock's recent trading levels.
AdThe negative analyst sentiment was compounded by a broader market decline, with the S&P 500, Dow Jones, and Nasdaq all trading lower. This backdrop amplified the selling pressure on Lemonade, overshadowing the company's recent operational news, such as the expansion of its renters insurance product and a renewed reinsurance program.